CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Safe Rooms for the Management of Patients Experiencing Crystal Methamphetamine-Induced Psychosis: Clinical and Cost-Effectiveness and Guidelines

Last updated: December 21, 2018
Project Number: RB1294-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of safe rooms to manage patients experiencing crystal methamphetamine-induced psychosis?
  2. What is the cost- effectiveness of safe rooms to manage patients experiencing crystal methamphetamine-induced psychosis?
  3. What are the evidence-based guidelines regarding the use of safe rooms to manage patients experiencing crystal methamphetamine-induced psychosis?

Key Message

No relevant literature was identified regarding the clinical effectiveness or cost-effectiveness of safe rooms to manage patients experiencing crystal methamphetamine-induced psychosis. Additionally, no relevant evidence-based guidelines were identified.